AHA

Day One at the American Heart Association Meeting

drummer boy The Drums of change began to beat in Chicago. Change from understanding existing science and from understanding the promise of science to come in the next 4 days. American Heart Association Meetings are always interesting and frequently change the way heart doctors practice their skill, the medicines they use and we all gain from the improved results (outcomes) that come to light in major studies.

Members Only: 

Drummer The Drums of change began to beat in Chicago.

Change from understanding existing science and from understanding the promise of science to come in the next 4 days. American Heart Association Meetings are always interesting and frequently change the way heart doctors practice their skill, the medicines they use and we all gain from the improved results (outcomes) that come to light in major studies.

Today there was a fascinating lecture on cardio-renal syndrome--a clinical problem where a failing or declining heart begins to change the way the kidney works. As usual, the science strained the memory on things long past in Medical, Nursing or Pharmacy school, yet the presenters were kind in their review and rigorous in their science.

Later there was an extremely well designed and presented and discussed satellite symposium on medicines that prevent clost after a heart attack, stent placement or heart blood vessel replacements (CABG). Some of the best minds in heart disease openly discussed medicines that make our platelets slippery and keep blood vessels open after the surgeon has repaired our heart pluumbing or the interventional cardiologist has opened a clogged vessel with angioplasty and then inserted a stent.

Tomorrow will bring some crucial information on Natrecor in heart failure. The ASCEND HF study will be part of the late breaking clinical trials presented at 10 AM and may change the very guidelines that your doctor now uses and how he or she uses an exiting drug called Natrecor.

Tomorrow also offers new Inspra data which could again actually change the guidelines your doctor uses if you have a heart attack! Inspra (generic eplerenone) will be the focus of EMPHASIS HF and could offer great hope to people with NYHA class 2 heart failure!

Great days for heart science

skyline  The American Heart Association will hold its annual Scientific Sessions meeting in Chicago this year. Visit www.americanheart.org for more info on this event !

Start Date: 
Mon, 10/25/2010

The American Heart Association Meeting November 13-17th

skyline   The American Heart Association meeting will be in Chicago this year. Expect a barage of interesting cardiovascular news to start hitting the media on November 14th.

This website is not intended as medical advice, and you should consult your doctor before changing or adding any medicines or vitamins to those you may now be taking and about applying any strategies BEFORE you adopt any approach in this report. While diligent care has been taken to ensure the accuracy of the information provided during the preparation of this edition, no claim is made that all known actions, uses or side effects, strategies for cost containment, targets or cholesterol pathways are included in this report. The accuracy and currentness of information are ever subject to change relative to new guidelines, new information derived from drug research, development and general usage.